Image Source: Pixabay

While U.S. stocks are often among the most popular among dividend investors, there is considerable value to be found among international stocks at the moment.

Investors can find dividend stocks across multiple market sectors, such as energy and healthcare, in which international stocks have higher yields and lower valuations than their U.S. based peers.

In this article, we will cover 3 high yield international dividend stocks that could provide investors with a powerful combination of high income alongside long-term growth.

Open Text Corporation (OTEX)

Open Text was founded in 1991. It provides information management solutions, including cloud solutions. It operates in 180 countries and its annual recurring revenue (“ARR”) represents about 79% of total revenue.

Its ARR includes cloud services, subscriptions, and customer support. Open Text reported its fiscal Q3 2025 results on 04/30/2025. For the quarter, revenue fell 13% year-over-year to $1.3 billion. Adjusted for the divestiture of its AMC/Mainframe business to Rocket Software, which was completed on May 1, 2024, revenue fell 4.5%.

ARR was $1.0 billion, down 10% year-over-year. Again, adjusted for the divestiture, ARR was down 2.8%. Cloud revenues were $463 million, up 1.8% year-over-year.

Operating cash flows and free cash flows were $402 million and $374 million, respectively, which were up 4.6% and 7.4% versus a year ago. Adjusted EBITDA, a cash flow proxy, fell 15% to $395 million with a margin of 31.5%.

OTEX also generated operating cash flow and free cash flow of $711 million and $563 million, respectively. OTEX has increased its dividend for 11 consecutive years.

Novartis AG (NVS)

Novartis researches, develops, and markets products to improve patients’ health. The company offers medicines in the areas of oncology, cardiovascular, dermatology, respiratory, and several others. Novartis employs 76,000 people and has annual sales of about $54 billion.

Novartis is incorporated in Switzerland, but U.S. investors have access to the company through an American Depositary Receipt, or ADR.

On April 29th, 2025, Novartis reported first quarter results. All figures are in U.S. dollars. For the quarter, revenue grew 11.9% to $13.23 billion, which was $183 million above estimates. Adjusted earnings-per-share of $2.28 compared to $1.80 in the prior year and was $0.11 better than expected.

Volume improved 15% and pricing was up slightly, but this was offset by a 2% headwind from generic competition. Revenue for Entresto, which is used to treat chronic heart failure and is the company’s top grossing product, grew by 22% to $2.3 billion as the product continues to grow in all markets, especially in China and Japan.

Cosentyx, which treats plaque psoriasis, improved 18% to $1.5 billion as demand remains high in the U.S., Europe, and emerging growth markets due to recent launches and volume growth in key indications.

NVS has increased its dividend for 29 consecutive years, in its home currency.

Unilever plc (UL)

Unilever is one of the largest consumer goods companies in the world, producing and marketing ~400 brands in nearly 200 countries. Well-known brands include Ben & Jerry’s, Q-tips, Vaseline, Axe, Dove, Hellmann’s, Knorr and many more. Its products are used by more than 3 billion people every day. It has a market capitalization of $137 billion.

In late April, Unilever reported (4/24/25) sales for the first quarter of fiscal 2025. It grew its underlying sales 3.0% over the prior year thanks to 1.7% price hikes and 1.3% volume growth. The 30 most powerful brands grew their sales 3.0% and thus comprised more than 75% of total sales.

The strong brands of the company have enabled it to raise prices aggressively without a significant effect on volume in the last three years. However, as consumers have become more price-sensitive, price hikes have moderated in recent quarters. Unilever reiterated its guidance for sales growth of 3% 5% in 2025 and a modest improvement in operating margin (vs. 18.4% in 2024), in line with its long-term guidance.

Unilever has stated that it will pursue growth aggressively in some emerging markets in Asia, such as India, China, Vietnam, Bangladesh, Pakistan and Myanmar. These markets are characterized by rapidly growing populations and an emerging middle class and thus they are very promising. Management has provided guidance for 3%-5% adjusted annual revenue growth in the long run.

Unilever has a significant competitive advantage, namely the strength of its brands. The company generates ~80% of its sales from the #1 or #2 position in its markets. Thanks to the strength of its brands and its great execution in its growth initiatives, Unilever has always been more resilient to recessions than the vast majority of stocks. As a result, Unilever has been able to raise its dividend for 43 consecutive years in its home currency.

UL currently yields 3.3%.

More By This Author:

10 Overvalued Dividend Stocks To Sell
10 Stocks For Long-Term Dividend Compounding
3 Dividend Growth Stocks For Long-Term Compounding